Advanced Medical Solutions Grp PLC
22 January 2007
Advanced Medical Solutions Group plc
Holding in Company
Advanced Medical Solutions Group plc (the 'Company') received notification on 19
January 2007 from AXA Investment Management UK Ltd that AXA S.A. and its group
companies are interested in 16,937,661 ordinary shares of 5 pence each ('
Ordinary Shares'), representing 11.92 per cent of the Company's issued share
capital. This interest comprises a beneficial interest of 165,161 Ordinary
Shares and a non-beneficial interest of 16,772,500 Ordinary Shares, as detailed
below:
Name of the Company/Fund Particulars of the Registered as Interest
Beneficial Owners
Sun Life Pensions Management Ltd Sun Life Pensions Smith & Williamson 150,000
(Beneficial) Management Ltd Nominees Limited
Sun Life Pensions Management Ltd Sun Life Pensions BNY (OCS) Nominees 15,161
(Beneficial) Management Ltd Limited
AXA Framlington 10,000,000
Framlington Innovative Growth
(Non- Beneficial)
AXA Framlington 2,550,000
Biotech
(Non- Beneficial)
LX0901 2,022,500
(Non- Beneficial)
LX1068 2,200,000
(Non- Beneficial)
Total 16,937,661
This information is provided by RNS
The company news service from the London Stock Exchange RAUAR
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.